|
Name |
Preussilide B
|
| Molecular Formula | C25H34O4 | |
| IUPAC Name* |
(2E,4E,6E)-7-[(1R,6R,7R,8S,8aS)-7-hydroxy-3,6,8-trimethyl-2-(2-oxopropyl)-1,5,6,7,8,8a-hexahydronaphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoic acid
|
|
| SMILES |
C[C@@H]1CC2=CC(=C([C@@H]([C@H]2[C@@H]([C@@H]1O)C)/C=C(\C)/C=C(\C)/C=C/C(=O)O)CC(=O)C)C
|
|
| InChI |
InChI=1S/C25H34O4/c1-14(7-8-23(27)28)9-15(2)10-22-21(13-18(5)26)16(3)11-20-12-17(4)25(29)19(6)24(20)22/h7-11,17,19,22,24-25,29H,12-13H2,1-6H3,(H,27,28)/b8-7+,14-9+,15-10+/t17-,19+,22+,24+,25-/m1/s1
|
|
| InChIKey |
WPOOLKYXEKIQSJ-FKYFWVDISA-N
|
|
| Synonyms |
Preussilide B; CHEMBL4128814; J3.662.981I
|
|
| CAS | NA | |
| PubChem CID | 132489953 | |
| ChEMBL ID | CHEMBL4128814 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 398.5 | ALogp: | 3.9 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 74.6 | Aromatic Rings: | 2 |
| Heavy Atoms: | 29 | QED Weighted: | 0.466 |
| Caco-2 Permeability: | -5.032 | MDCK Permeability: | 0.00002880 |
| Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.061 |
| Human Intestinal Absorption (HIA): | 0.479 | 20% Bioavailability (F20%): | 0.57 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.011 | Plasma Protein Binding (PPB): | 96.88% |
| Volume Distribution (VD): | 1.557 | Fu: | 3.44% |
| CYP1A2-inhibitor: | 0.119 | CYP1A2-substrate: | 0.114 |
| CYP2C19-inhibitor: | 0.074 | CYP2C19-substrate: | 0.808 |
| CYP2C9-inhibitor: | 0.463 | CYP2C9-substrate: | 0.862 |
| CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.106 |
| CYP3A4-inhibitor: | 0.102 | CYP3A4-substrate: | 0.465 |
| Clearance (CL): | 1.337 | Half-life (T1/2): | 0.921 |
| hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.345 |
| Drug-inuced Liver Injury (DILI): | 0.057 | AMES Toxicity: | 0.04 |
| Rat Oral Acute Toxicity: | 0.59 | Maximum Recommended Daily Dose: | 0.901 |
| Skin Sensitization: | 0.883 | Carcinogencity: | 0.492 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
| Respiratory Toxicity: | 0.976 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003387 | ![]() |
0.750 | D05QDC | ![]() |
0.282 | ||
| ENC003386 | ![]() |
0.750 | D0G3PI | ![]() |
0.271 | ||
| ENC003389 | ![]() |
0.635 | D02DGU | ![]() |
0.271 | ||
| ENC003384 | ![]() |
0.621 | D00DKK | ![]() |
0.271 | ||
| ENC003388 | ![]() |
0.524 | D0B1IP | ![]() |
0.246 | ||
| ENC003852 | ![]() |
0.337 | D0E9KA | ![]() |
0.223 | ||
| ENC003167 | ![]() |
0.302 | D0X7XG | ![]() |
0.222 | ||
| ENC003854 | ![]() |
0.300 | D0W2EK | ![]() |
0.213 | ||
| ENC003853 | ![]() |
0.300 | D0FG6M | ![]() |
0.209 | ||
| ENC002015 | ![]() |
0.279 | D0S7WX | ![]() |
0.207 | ||